WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ATHA stock forecasts and price targets.

Forecast return on equity

Is ATHA forecast to generate an efficient return?

Company
N/A
Industry
262.26%
Market
146.96%

Forecast return on assets

Is ATHA forecast to generate an efficient return on assets?

Company
N/A
Industry
110.56%

ATHA earnings per share forecast

What is ATHA's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$6.62
Avg 2 year Forecast
-$4.94
Avg 3 year Forecast
-$0.20

ATHA revenue forecast

What is ATHA's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

ATHA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHA$4.07N/AN/A
ABP$0.20N/AN/A
PALI$1.74$16.00+819.54%Strong Buy
LPCN$2.90$8.00+175.86%Buy
PCSA$0.31$1.00+222.58%Buy
View Top Biotech Stocks

Athira Pharma Stock Forecast FAQ

What is ATHA's earnings growth forecast for 2025-2027?

(NASDAQ: ATHA) Athira Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 27.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.33%.

Athira Pharma's earnings in 2025 is -$59,853,000.On average, 4 Wall Street analysts forecast ATHA's earnings for 2025 to be -$26,108,048, with the lowest ATHA earnings forecast at -$25,084,203, and the highest ATHA earnings forecast at -$26,875,931. On average, 4 Wall Street analysts forecast ATHA's earnings for 2026 to be -$19,470,408, with the lowest ATHA earnings forecast at -$20,020,981, and the highest ATHA earnings forecast at -$18,635,083.

In 2027, ATHA is forecast to generate -$804,562 in earnings, with the lowest earnings forecast at -$773,011 and the highest earnings forecast at -$828,226.

If you're new to stock investing, here's how to buy Athira Pharma stock.

What is ATHA's revenue growth forecast for 2025-2027?

(NASDAQ: ATHA) Athira Pharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 108.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.15%.

Athira Pharma's revenue in 2025 is $0.On average, 3 Wall Street analysts forecast ATHA's revenue for 2025 to be $0, with the lowest ATHA revenue forecast at $0, and the highest ATHA revenue forecast at $0. On average, 3 Wall Street analysts forecast ATHA's revenue for 2026 to be $0, with the lowest ATHA revenue forecast at $0, and the highest ATHA revenue forecast at $0.

In 2027, ATHA is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is ATHA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ATHA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 110.56%.

What is ATHA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ATHA) Athira Pharma's current Earnings Per Share (EPS) is -$15.50. On average, analysts forecast that ATHA's EPS will be -$6.62 for 2025, with the lowest EPS forecast at -$6.36, and the highest EPS forecast at -$6.81. On average, analysts forecast that ATHA's EPS will be -$4.94 for 2026, with the lowest EPS forecast at -$5.08, and the highest EPS forecast at -$4.73. In 2027, ATHA's EPS is forecast to hit -$0.20 (min: -$0.20, max: -$0.21).

What is ATHA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ATHA) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.